SkyMirr
OperatingSkyMirr Inc.
Healthcare · Melbourne, FL · Founded 2021
RF technology to better our lives
Financials
FY2020–FY2025 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps markedA dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Team
7 people
Over 30 years of experience in executive roles such as CEO in IT/Display/Wireless Industries. Industry leader in business development/fundraising/startups. Currently CEO of Nano-Photonica and Operating Partner at Orchid Black. Ph.D. in Communication Systems from University of Pennsylvania
Over 25 years of experience in RF/antenna technology and operations management. Various executive/technical positions including CEO, CTO, COO, VP and President for industry leading companies such as Taoglas, SkyCross, Samsung Electronics, etc. Over 35 patents for antenna and RF system design. Ph.D. in Electrical Engineering from Florida Tech.
30 years of experience in various VP roles leading wireless company including Globalstar, L3-Communications, ACR Electronics, etc. Business Development, R&D, Product Development and Volume Manufacturing. Over 10 patents for RF/antenna and communication systems design. MBA and MSEE from University of Florida
Over 30 years of experience in RF/Antenna/Medical areas as an academic/industrial leader such as Professor of Soonchunhyang University, Senior researcher in LGE, and Chairman of ITS (Intelligent Transportation System), the honored academic institute in Korea. Published over 316 papers and 34 patents. Ph.D. in Electronic Communication Engineering from Hanyang University
Over 25 years of experience in finance/accounting leadership positions such as CFO and VP of Finance in companies in multiple industries including Trident Microsystems and Skye Bioscience. Currently serving Bluestar Genomics as CFO. Richard helped raise over $100M in venture and secondary offerings, taken companies through IPO, completed M&A transactions valued at ~$500M, and expanded global operations.
Names and titles as disclosed on StartEngine, SEC Form C. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
Filed 4 of 4 annual reports (FY2022–FY2025)
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.